Oral Cannabidiol in the Treatment of Myofascial Pain Disorder of the Temporomandibular Region: A Placebo-Controlled Randomized Clinical Trial.
The oral cannabidiol myofascial pain disorder trial investigates CBD's efficacy for temporomandibular pain. This placebo-controlled randomized clinical trial evaluates pain reduction and jaw function. Results could inform future treatment options for…
Analgesic Effect of Cannabinoids for Fibromyalgia: A Systematic Review and Meta-Analysis.
This systematic review and meta-analysis examines cannabinoid analgesic effects fibromyalgia patients experience. It provides evidence on cannabinoids as a potential treatment for fibromyalgia pain. The study highlights the importance of considering…
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
This systematic review evaluates cannabinoid efficacy dementia symptoms including agitation, anxiety, and depression in patients with dementia. It highlights cannabinoids as a potential safer alternative to traditional antipsychotics. The study…
Does oral cannabidiol oil in adjunct to pain medications help reduce pain and improve locomotion in dogs with osteoarthritis?
Oral cannabidiol oil osteoarthritis dogs is studied as an adjunct to conventional pain medications. Evidence suggests it may help reduce pain and improve locomotion in dogs with osteoarthritis. This research supports cautious optimism while awaiting…
Medical Cannabis for Orthopaedic Pain: Promising Signal, Weak Evidence Base
The 2025 medical cannabis orthopaedic pain review highlights minimal high-quality evidence supporting efficacy in orthopaedic pain. Most positive findings compare cannabis to placebo or no treatment, with scarce data against active analgesics. This…
Cannabis Impairs Driving for Over Five Hours—Far Longer Than Users Believe
A recent study on cannabis driving impairment duration found that impairment lasts over five hours after use. Despite this, many users believe they are fit to drive sooner. Blood THC levels did not reliably predict driving performance in the study.
Cannabinoid Clinical Trials: CBD for Autism in Children
The CBD autism clinical trial study investigated oral CBD oil effects on autistic children aged 5 to 12 over 12 weeks. Results showed potential benefits for social relating, anxiety, and parental stress. This controlled trial provides early clinical…
Cannabinoids for Autism: Clinical Evidence & ECS Research
Cannabinoids for autism clinical evidence shows early promise in reducing irritability and hyperactivity in autism spectrum disorder. Current studies are limited but suggest potential benefits. More research is needed to confirm efficacy and safety.
Review of Cannabinoid Clinical Trials for Mental Disorders Safety
This cannabinoid clinical trials mental disorders safety review examines randomized controlled trials assessing efficacy and safety. Evidence remains limited and inconclusive for cannabinoids as treatments. Clinicians should interpret claims cautiously…
Cannabidiol for Fibromyalgia: Clinical Trial Evidence and Analysis
This cannabidiol clinical trial fibromyalgia study found no superiority of CBD over placebo in reducing pain. The trial highlights the gap between patient use and clinical evidence. Clinicians should guide fibromyalgia patients based on evolving research.